The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.

Journal Article (Journal Article)

BACKGROUND: A major impediment to the transplanting of porcine organs into humans is the susceptibility of porcine organs to acute vascular rejection, which can destroy a vascularized xenograft over a period of hours to days. Acute vascular rejection of porcine-to-primate xenografts is thought to be triggered by binding of xenoreactive antibodies to the graft. We tested whether antibodies, binding to Galalpha1-3Gal epitopes in porcine tissue, initiate this phenomenon. METHODS AND RESULTS: Specific depletion of anti-Galalpha1-3Gal antibodies from the blood of baboons, using extracorporeal perfusion of separated plasma through columns of Sepharose beads covalently linked to the antigenic trisaccharide, Galalpha1-3Galbeta1-4GlcAc, averted the development of acute vascular rejection in porcine organs transgenic for human decay-accelerating factor and CD59. More importantly, after immunodepletion was stopped and Gala1-3Gal antibodies were allowed to return, these same organs continued to function and remained pathologically normal and thus seemed to achieve a state of accommodation. CONCLUSION: These results demonstrate that anti-Galalpha1-3Gal antibodies cause acute vascular rejection and suggest that depletion of these antibodies leads to accommodation of the donor cardiac xenograft and could supply an important model for additional study.

Full Text

Duke Authors

Cited Authors

  • Lin, SS; Hanaway, MJ; Gonzalez-Stawinski, GV; Lau, CL; Parker, W; Davis, RD; Byrne, GW; Diamond, LE; Logan, JS; Platt, JL

Published Date

  • December 27, 2000

Published In

Volume / Issue

  • 70 / 12

Start / End Page

  • 1667 - 1674

PubMed ID

  • 11152095

International Standard Serial Number (ISSN)

  • 0041-1337

Digital Object Identifier (DOI)

  • 10.1097/00007890-200012270-00002


  • eng

Conference Location

  • United States